DIA Biosimilars 2013

Xceleron

Xceleron, Kinetigen partner for early trials

Monday, March 4, 2013 02:04 PM

Xceleron, which uses ultra-sensitive analytical technology to design and execute clinical trials, is partnering with Kinetigen, a clinical pharmacology consulting firm specializing in pharmacokinetics. The partnership will offer drug developers simpler and more robust early clinical investigations.

More... »

Cenduit: Now with Patient Reminders

Xceleron, Kinetigen partner to simplify phase I investigations

Tuesday, February 26, 2013 09:06 AM

Xceleron, a provider of bioanalytical AMS services for accelerated early drug development, has formed a partnership with Kinetigen, a clinical pharmacology consulting firm specializing in pharmacokinetics. The partnership will offer drug developers simpler and more robust early clinical investigations.

More... »

CRF Health – eCOA Forum

Xceleron, Crystal Pharmatech to improve early clinical development

Wednesday, January 23, 2013 09:59 AM

Xceleron, a Germantown, Md.-based CRO that applies ultra-sensitive analytical technology to novel clinical designs, has formed a partnership with Crystal Pharmatech, a China-based technology-driven research CRO.

More... »

Xceleron to move to purpose-built laboratories in U.S.

Wednesday, February 8, 2012 10:01 AM

Albion Ventures and Solon Ventures have invested $2.4 million in Xceleron, a U.K.-based bioanalytical Accelerator Mass Spectrometry (AMS) service, to locate all of its business to its custom-built facility in Germantown, Md., which is expected to be fully operational by March 31, 2012.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs